You are here

Article info

Article menu
Movement disorders
Short report
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study

Authors

  • Caroline Moreau Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, FranceEA4559, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Arnaud Delval Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Vincent Tiffreau EA 4488, Department of Rehabilitation Medicine, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Luc Defebvre Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, FranceEA4559, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Kathy Dujardin Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, FranceEA4559, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Alain Duhamel Department of Biostatistics, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Gregory Petyt Department of Nuclear Medicine, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Claude Hossein-Foucher Department of Nuclear Medicine, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • David Blum Department of Molecular Biology, INSERM U837/1 JPARC, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Bernard Sablonnière Department of Molecular Biology, INSERM U837/1 JPARC, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Susanna Schraen Department of Molecular Biology, INSERM U837/1 JPARC, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Delphine Allorge Department of Biology and Toxicology, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Alain Destée Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, FranceINSERM U837/6 JPARC, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • Régis Bordet Department of Medical Pharmacology, University of Lille Nord de France and Lille University Hospital, Lille, FranceDepartment of Pharmacology, EA 1046, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  • David Devos Department of Neurology, University of Lille Nord de France and Lille University Hospital, Lille, FranceEA4559, University of Lille Nord de France and Lille University Hospital, Lille, FranceDepartment of Medical Pharmacology, University of Lille Nord de France and Lille University Hospital, Lille, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Devos, Département de Pharmacologie Médicale, Université Lille Nord de France, CHRU de Lille, Lille F-59037, France; david.devos{at}chru-lille.fr
View Full Text

Citation

Moreau C, Delval A, Tiffreau V, et al
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
Journal of Neurology, Neurosurgery & Psychiatry 2013;84:552-555.

Publication history

  • Received May 9, 2012
  • Revised August 28, 2012
  • Accepted September 3, 2012
  • First published October 16, 2012.
Online issue publication 
April 08, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode